Process for the preparation of lapatinib

作者: Venkaiah Chowdary Nannapaneni , Venkata Reddy Satti , Sambasiva Rao Talasila , Pulla Reddy Muddasani , Satish Chowdary Nekkanti

DOI:

关键词:

摘要: Present process relates to an improved and commercial for the preparation of lapatinib formula-I or its pharmaceutically acceptable p-toluenesulfonate salt involving novel intermediates formulae-XVII, XVIII, XIX. utilizes Meerwein reaction as a key step in aryl C-C bond formation avoiding costly boronate coupling chemistry used conventional synthesis lapatinib.

参考文章(24)
Alessandro Leganza, Francesco Fontana, Sergio Osti, Impurity of lapatinib and salts thereof ,(2012)
David Malcolm Crowe, Tim Chien Ting Ho, Andrew Simon Craig, Michael S. Mcclure, Quinazoline salt compounds ,(2008)
Bandi Vamsi Krishna, Bandi Parthasaradhi Reddy, Dasari Muralidhara Reddy, Rapolu Raji Reddy, Thungathurthy Srinivasa Rao, Kura Rathnakar Reddy, Salts of lapatinib ,(2011)
Bhujanga rao Adibhatla Kali Satya, Ramanadham Jyothi Prasad, Nannapaneni Venkaiah Chowdary, A novel process for the preparation of lapatinib and its pharmaceutically acceptable salts ,(2009)
David M. Crowe, Andrew Simon Craig, Michael Millan, Quinazoline ditosylate anhydrate forms ,(2008)
Tona Morgan GlaxoSmithKline Gilmer, Arundathy Nirmalini GlaxoSmithKline Pandite, Mark S. GlaxoSmithKline Upper Providence Berger, Cancer treatment method ,(2005)
Joel B. Silver, Feng Xu, Nicholas Valiante, Compounds for immunopotentiation ,(2005)
Qingmin Yang, Zhongru Guo, Shaobo Yang, Minghui Zhang, Ying Li, Long Zhang, Jianrong Zhu, Shousheng Yan, Chuanwen Fan, Jingyi Wang, 4-(Substituted Anilino)-Quinazoline Derivatives Useful as Tyrosine Kinase Inhibitors ,(2010)